{
  "ticker": "NGS",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963683",
  "id": "02963683",
  "pages": 9,
  "price_sensitive": false,
  "date": "20250630",
  "time": "1404",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250630/pdf/06l8bnrqc8npxw.pdf",
  "summary": "### **Summary of Material Information (ASX: NGS \u2013 CEO AGM Address & Business Update)**  \n\n#### **Financial & Operational Highlights**  \n- **FY2024 Performance**:  \n  - Sales: **$2.48M USD ($3.82M AUD)**.  \n  - Operating loss: **$2,832K USD ($4,357K AUD)**, down 8% YoY.  \n- **Q1 2025 Performance**:  \n  - Revenue: **$447K USD ($688K AUD)**.  \n  - Operating loss: **$273K USD ($420K AUD)**, a **61% improvement** vs. 2024 quarterly average.  \n  - Further cost reductions implemented in Q2.  \n\n#### **Strategic Developments**  \n- **Retail Expansion**:  \n  - **CVS rollout** (orders shipping; sales commence August 2025).  \n  - **Walmart** renewed modular for KidzProtein + added 3rd flavor.  \n  - **Wakefern** expansion planned for H2.  \n- **International Markets**:  \n  - Initial export shipments to **China and Vietnam**.  \n- **Capital Raise**: Completed to fund inventory and expansion (amount not specified).  \n\n#### **Forward Outlook**  \n- Focus on **North American retail growth**, e-commerce (Amazon/iHerb), and export markets.  \n- Targeting **breakeven** via cost control and revenue initiatives.  \n\n**No material capital markets actions (e.g., raising, timetable) identified.**",
  "usage": {
    "prompt_tokens": 2160,
    "completion_tokens": 314,
    "total_tokens": 2474,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-30T04:43:56.651019"
}